Condition

Non Erosive Reflux Disease (4)

Chronic Gastritis (1)

Dyspepsia (1)

GERD (1)

Gastroesophageal Reflux Disease (1)

Overall Status

Completed (2)

Unknown status (1)

Withdrawn (1)

Phase

n/a (1)

phase 3 (1)

phase 4 (1)

Sponsor

Ahn-Gook Pharmaceuticals Co.,Ltd (1)

AstraZeneca (1)

Instituto Ecuatoriano de Enfermedades Digestivas (1)

Virginia Commonwealth University (1)

Collaborator

Medical University of South Carolina (1)

Ochsner Health System (1)

Intervention

confocal endomicroscopy (1)

esomeprazole (1)

optical enhancement (1)

optical enhancement with optical magnification (1)

optical magnification without optical enhancement (1)

placebo (1)

proton pump inhibitor (1)

s-pantoprazole 10mg (1)

sucralfate (1)

Study Documents

Intervention Type

drug (3)

device (2)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (3)

Observational (1)

non erosive reflux disease

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Minimal Injuries From Esophagus Detected by Optical Enhancement

Completed

Non Erosive Reflux Disease
GERD

Optical Enhancement
+2 more

Guayaquil, Guayas, Ecuador

Ecuadorian Institute of Digestive Diseases, Omnihospital

Jan 7, 2016

Gastroesophageal Reflux Disease, Non Erosive Reflux Disease, Dyspepsia Trial in Kenner, Charleston, Richmond (Confocal

Withdrawn

Gastroesophageal Reflux Disease
+2 more

Confocal endomicroscopy
+2 more

Kenner, Louisiana
+2 more

Dec 7, 2015

Non Erosive Reflux Disease Trial in Korea, Republic of (S-pantoprazole 10mg, Placebo)

Unknown status

Non Erosive Reflux Disease

S-pantoprazole 10mg
Placebo

Sung-Nam, Gyeong-gi, Korea, Republic of
+9 more

Oct 24, 2014

Non Erosive Reflux Disease, Chronic Gastritis Trial in China (Esomeprazole)

Completed

Has Results

Non Erosive Reflux Disease
Chronic Gastritis

Esomeprazole

Guangzhou, Guangdong, China
+7 more

Sep 26, 2012